Clinical Trials Logo

Clinical Trial Summary

The injection of autologous blood Blood Patch (BP) into the epidural space is the standard treatment for headache associated with intracranial hypotension. It provokes cerebral vasoconstriction. It is cons-indicated in a number of situations (HIV positive, fever, sepsis, leukemia). The purpose of this study is to evaluate another technique using a patch made by injecting an epidural hydroxyethylstarch solution (HES 130, 0.4, 6%) instead of blood patch. This alternative technique is simple to implement and does not have some of the specific blood pressure contra-indications. The study aims at comparing the "Blood Patch" group versus the "HES Patch" in terms of clinical efficacy , tolerance, satisfaction of the anesthetist, ease of implementation and effect of the injection of epidural anesthesia on cerebral blood flow within 24 hours.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02570724
Study type Interventional
Source University Hospital, Strasbourg, France
Contact
Status Completed
Phase N/A
Start date June 2013
Completion date August 2018

See also
  Status Clinical Trial Phase
Completed NCT03041441 - Non-invasive Estimation of CSF Pressure Using MRI in Patients With Spontaneous Intracranial Hypotension N/A
Completed NCT03276494 - Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access Phase 2
Not yet recruiting NCT04301830 - Postoperative Changes in Optic Nerve Sheath Diameter in Patients Undergoing Spinal Anesthesia for Cesarean Delivery